6 Papers
Kai-Yan Yang is an academic researcher from First Affiliated Hospital of Wenzhou Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Primary intravascular large B-cell lymphoma of the lung: a review and case report
TL;DR: Primary pulmonary IVLBCL of the lung is extremely rare, on chest CT it manifests as diffuse ground glass shadow, or nodular consolidations in the lung, lactate dehydrogenase and C-reactive protein was found to increase, fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) is an important and significant diagnostic modality in its early diagnosis.
Mir-4746 inhibits the proliferation of colorectal cancer cells in vitro and in vivo by targeting CCND1.
Yuehan Ren,Yun Li,Weiguang Zhang,Kai-Yan Yang,Jinlei Li,Yiwang Hu,Zhigui Zuo,Chang Xu,Yi-fei Pan,Xiaodong Zhang +9 more
TL;DR: Wang et al. as discussed by the authors found that the expression of mir-4746 is significantly downregulated in CRC tissues and cells, and that its expression level is closely associated with the tumor size and prognosis of clinical patients.
5
The immune checkpoint inhibitors treatment of head and neck squamous cell carcinoma: an expert consensus.
Lei Liu,Zhong-Zheng Xiang,Yi Liu,Wei Guo,Kai-Yan Yang,Jun Wang,Zhijun Sun,Guoxin Ren,Jianguo Zhang,Moyi Sun,Wei Ran,Guilin Huang,Zhangui Tang,Longjiang Li +13 more
TL;DR: In this article , the authors integrated the clinical experience of multi-disciplinary experts of head and neck cancers on the basis of current clinical hot issues and finally developed this consensus, to form a relatively unified understanding of immune checkpoint inhibitors treatment for head-and neck squamous cell carcinoma.
1
Comprehensive analysis of the prognosis and biological significance of RORβ in head and neck squamous cell carcinoma.
TL;DR: In this paper , the authors investigated the altered expression, clinical significance, prognostic value, and biological functions of RORβ in HNSCC, as well as its correlation with changes in the tumor immune microenvironment.
1
Combination immunochemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and meta-analysis
TL;DR: In this article , the authors evaluated the efficacy and safety of combination immunochemotherapy regimens for the treatment of recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC).